Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy

<b>Background</b>: Invasive and non-invasive pneumococcal diseases are significant health and economic burdens, especially in children and the elderly. Italy included the 7-valent (PCV7) and 13-valent pneumococcal conjugate vaccine (PCV13) in the National Immunization Program in 2007 and 2010, respe...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Filippo Ansaldi, Sarah Pugh, Daniela Amicizia, Roberto Di Virgilio, Cecilia Trucchi, Andrea Orsi, Alessandro Zollo, Giancarlo Icardi
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2020-01-01
Ráidu:	Pathogens
Fáttát:	cost-effectiveness analysis impact pneumococcal infections pneumococcal vaccines
Liŋkkat:	https://www.mdpi.com/2076-0817/9/2/76
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!